The Canadian Glomerulonephritis Registry (CGNR) and Translational Research Initiative: Rationale and Clinical Research Protocol

Keyphrases

• Biospecimen Collection 40%
• C3 Glomerulopathy 20%
• Human-based 20%
• IgA Nephropathy (IgAN) 20%
• Kidney Function Decline 20%
• Membranoproliferative Glomerulonephritis 20%
• Membranous Nephropathy 20%
• Molecular Research 20%
• Prevention of Progression 20%
• Registry Research 100%
• Remission of Proteinuria 20%
• Segmental Glomerulosclerosis 20%

Medicine and Dentistry

• Immunoglobulin A Nephropathy 20%
• Membranoproliferative Glomerulonephritis 20%
• Membranous Glomerulonephritis 20%
• Minimal Change Disease 20%
• Molecular Research 20%